デフォルト表紙
市場調査レポート
商品コード
1566208

ペンニードルの市場規模、シェア、成長分析、タイプ別、長さ別、用途別、地域別 - 産業予測、2024年~2031年

Pen Needles Market Size, Share, Growth Analysis, By Type (Standard Pen Needles, Safety Pen Needles), By Length (4mm, 5mm), By Application (Insulin Therapy, Growth Hormone Therapy), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 165 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ペンニードルの市場規模、シェア、成長分析、タイプ別、長さ別、用途別、地域別 - 産業予測、2024年~2031年
出版日: 2024年10月01日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ペンニードルの世界市場規模は、2022年に約13億米ドルと評価され、予測期間(2024-2031年)のCAGRは8.9%で、2023年の14億米ドルから上昇し、2031年には27億米ドルに達すると予測されています。

糖尿病の有病率が上昇を続ける中、ペンニードルの需要は大きく伸びると予想されます。国際糖尿病連合によると、2031年までに6億4,200万人以上が糖尿病患者となり、これらの必須医療機器の対象市場が堅調に拡大することを示しています。糖尿病患者がインスリンやその他の注射薬を定期的に使用することが、この需要をさらに後押ししており、特に糖尿病患者の80~85%が肥満と関連していることを考えると、危険因子が高まる。ランセットとペンニードルの実用性と効率性は、薬剤投与のための好ましい方法であり、その需要は患者の間でインスリンペンの採用が増加していることと直接相関しています。さらに、製品設計や製剤において予想される技術的進歩が、予測期間を通じてランセットおよびペンニードル市場のさらなる成長に拍車をかけると思われます。特に米国では、ペンニードル市場はこれらの動向に牽引され、今後数年間にわたって持続的なCAGRを享受すると予測されています。このため、この分野の利害関係者やメーカーは、糖尿病人口の拡大と、それに伴う効果的で使い勝手の良い注射方法へのニーズを活用する態勢を整える必要があります。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場のエコシステム
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • 特許分析
  • 顧客と購買基準の分析
  • ケーススタディ分析
  • 技術分析

ペンニードル市場:タイプ別

  • 市場概要
  • 標準ペンニードル
  • 安全性ペンニードル

ペンニードル市場:長さ別

  • 市場概要
  • 8mm
  • 5mm
  • 6mm
  • 4mm
  • 12mm
  • 10mm

ペンニードル市場:用途別

  • 市場概要
  • インスリン療法
  • グルカゴン様ペプチド-1療法(GLP-1療法)
  • 成長ホルモン療法
  • 骨粗鬆症
  • その他の用途

ペンニードル市場:環境別

  • 市場概要
  • 在宅ケア環境
  • 病院と診療所
  • その他の環境

ペンニードル市場:購入方法別

  • 市場概要
  • 処方箋に基づく購入
  • 店頭購入
  • オンライン購入
  • その他の購入方法

ペンニードル市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Becton, Dickinson and Company(BD)
  • Novo Nordisk A/S
  • Ypsomed AG
  • Owen Mumford Ltd.
  • Terumo Corporation
  • HTL-STREFA S.A.
  • Allison Medical, Inc.
  • UltiMed, Inc.
  • Artsana S.p.A.
  • Trividia Health, Inc.
  • MedExel Co., Ltd.
  • Haselmeier GmbH
  • Delfu Medical Device Co., Ltd.
  • Shanghai Neo-Medical Co., Ltd.
  • Henso Medical(Hangzhou)Co., Ltd.
目次
Product Code: SQMIG35A2722

Global Pen Needles Market size was valued at around USD 1.3 billion in 2022 and is expected to rise from USD 1.4 billion in 2023 to reach a value of USD 2.7 billion by 2031, at a CAGR of 8.9% over the forecast period (2024-2031).

As the prevalence of diabetes continues to rise, the demand for pen needles is expected to grow significantly. According to the International Diabetes Federation, more than 642 million individuals will be living with diabetes by 2031, indicating a robust expansion in the target market for these essential medical devices. Regular usage by diabetic patients for insulin or other injectable medications further underpins this demand, particularly given that 80-85% of diabetes cases are linked to obesity, which heightens risk factors. The practicality and efficiency of lancet and pen needles make them the preferred methods for administering medication, and their demand is directly correlated with the increasing adoption of insulin pens among patients. Furthermore, anticipated technological advancements in product designs and formulations will likely spur further growth in the lancet and pen needle market throughout the forecast period. Particularly in the US, the pen needles market is projected to enjoy a sustainable compound annual growth rate (CAGR) over the coming years, driven by these trends. As such, stakeholders and manufacturers within this sector should be poised to capitalize on the expanding diabetes population and the resulting need for effective and user-friendly injection methods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pen Needles market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pen Needles Market Segmental Analysis

Global Pen Needles Market is segmented by Type, Length, Application, Mode of purchase, Setting and region. Based on Type, the market is segmented into Standard Pen Needles, and Safety Pen Needles. Based on Length, the market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. Based on Application, the market is segmented into Insulin Therapy, GLP-1 Therapy, Growth Hormone Therapy, Osteoporosis, and Other Applications. Based on Mode of purchase, the market is segmented into Prescription-based, Over the Counter, Online Purchase, and Other Modes of Purchase. Based on Setting, the market is segmented into Homecare, Hospitals & Clinics, and other settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Pen Needles Market

The escalating prevalence of chronic diseases such as diabetes, cardiovascular conditions, and multiple sclerosis is a significant market driver for the Global Pen Needles market. As more patients require frequent pen injections for medication management, the adoption of pen injectors has become the norm due to their ease of use, reliability, and suitability for self-administration. The removable nature of pen needles, along with their optimized length and sharpness, enhances the efficiency of drug delivery. This shift towards advanced pen needle technologies is crucial in accommodating the growing patient population and fostering better adherence to treatment regimens, thereby fueling market growth during the analysis period.

Restraints in the Global Pen Needles Market

The Global Pen Needles market faces significant restraints stemming from safety concerns and evolving treatment options. Despite their convenience, pen needles are associated with risks such as needlestick injuries, infections, and patient discomfort, along with potential hyperglycemia caused by the inability to adjust dosages accurately. Additionally, there has been a notable shift in diabetes management practices towards insulin pumps, which offer functionalities like automated insulin suspension that mitigate hypoglycemia risks. These factors collectively hinder market growth, as healthcare providers and patients increasingly seek alternatives that provide greater safety and more precise glucose management capabilities.

Market Trends of the Global Pen Needles Market

The Global Pen Needles market is witnessing a significant trend towards shorter and thinner needles, which cater to a broader demographic, particularly individuals with obesity. This evolution highlights the advantages of insulin pens over traditional syringes, as the latter often present challenges in self-administration due to their bulkiness. Pen needles are designed with fine-pointed tips, facilitating easier muscle penetration and potentially reducing pain during use. Moreover, they enhance safety in insulin delivery for diabetic patients, leading to increased adoption. As a result, these developments are propelling growth in the pen needles market during the analyzed period, reflecting a shift towards more user-friendly medical solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Pricing Analysis
  • Value Chain Analysis
  • Supply Chain Analysis
  • Patent Analysis
  • Customer & Buying Criteria Analysis
  • Case Study Analysis
  • Technology Analysis

Pen Needles Market, By Type

  • Market Overview
  • Standard Pen Needles
  • Safety Pen Needles

Pen Needles Market, By Length

  • Market Overview
  • 8Mm
  • 5Mm
  • 6Mm
  • 4Mm
  • 12Mm
  • 10Mm

Pen Needles Market, By Application

  • Market Overview
  • Insulin Therapy
  • Glucagon-Like Peptide-1 Therapy (Glp-1 Therapy)
  • Growth Hormone Therapy
  • Osteoporosis
  • Other Applications

Pen Needles Market, By Setting

  • Market Overview
  • Home Care Settings
  • Hospitals And Clinics
  • Other Settings

Pen Needles Market, By Mode Of Purchase

  • Market Overview
  • Prescription-Based Purchase
  • Over-The-Counter Purchase
  • Online Purchase
  • Other Modes Of Purchase

Pen Needles Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Becton, Dickinson and Company (BD)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novo Nordisk A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Owen Mumford Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HTL-STREFA S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allison Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UltiMed, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Artsana S.p.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trividia Health, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedExel Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haselmeier GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Delfu Medical Device Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai Neo-Medical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Henso Medical (Hangzhou) Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments